en

PRODUCT DETAIL

Polivy 140 mg prášok na koncentrát na infúzny roztok

Code 3475D
MA number EU/1/19/1388/001
Product Form: plc ifc 1x140 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU Orphan
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
L01FX Other monoclonal antibodies and antibody drug conjugates
L01FX14 Polatuzumab vedotin
Shelf life: 30
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 16.01.2020
Validity: 24.05.2027
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 24.10.2022
eu-flag.png sk-flag.png